Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 968 products on this category.

Product data	Purity	Price range	Estimated delivery
Carfilzomib Impurity 15 REF: 4Z-C-121018CAS: 1541171-67-8	- - -	To inquire	Thu 05 Dec 24
Nintedanib-d8 (Intedanib-d8) REF: 4Z-N-066045CAS: 1624587-87-6	- - -	To inquire	Thu 05 Dec 24
Lenvatinib Impurity 15 REF: 4Z-L-124019CAS: 417721-36-9	- - -	To inquire	Thu 05 Dec 24
Olaparib Impurity 15 REF: 4Z-O-032017CAS: 2250243-17-3	- - -	To inquire	Thu 05 Dec 24
Olaparib Impurity 25 REF: 4Z-O-032027CAS: 1423030-11-8	- - -	To inquire	Thu 05 Dec 24
Abiraterone-d4 REF: 4Z-A-821CAS: 2122245-62-7	- - -	To inquire	Thu 05 Dec 24
Palbociclib Impurity 56 REF: 4Z-P-196063CAS: 1974279-20-3	- - -	To inquire	Thu 05 Dec 24
Palbociclib REF: 4Z-P-196001CAS: 571190-30-2	- - -	To inquire	Thu 05 Dec 24
Nintedanib Impurity 13 (Intedanib Impurity 13) REF: 4Z-N-066027CAS: 66148-15-0	- - -	To inquire	Thu 05 Dec 24
Nintedanib Impurity 5 (Intedanib Impurity 5) REF: 4Z-N-066014CAS: 2410284-90-9	- - -	To inquire	Thu 05 Dec 24
Enzalutamide Impurity 11 REF: 4Z-E-068024	- - -	To inquire	Thu 05 Dec 24
Carfilzomib Impurity 2 REF: 4Z-C-121005CAS: 1541172-75-1	- - -	To inquire	Thu 05 Dec 24
5-9-Leuprorelin Ditrifluoroacetate (5-9-Leuprolide Ditrifluoroacetate) REF: 4Z-PL-4115CAS: 129244-90-2	- - -	To inquire	Thu 05 Dec 24
Nintedanib N4-Oxide Trifluoroacetate (Intedanib N4-Oxide Trifluoroacetate) REF: 4Z-N-066025	- - -	To inquire	Thu 05 Dec 24
Palbociclib Impurity 4 REF: 4Z-P-196008CAS: 1376615-91-6	- - -	To inquire	Thu 05 Dec 24
Leuprorelin (Leuprolide) Impurity 9 REF: 4Z-PL-4128CAS: 212388-38-0	- - -	To inquire	Thu 05 Dec 24
Abiraterone Impurity 15 REF: 4Z-A-8252CAS: 219843-76-2	- - -	To inquire	Thu 05 Dec 24
Carfilzomib Impurity 60 REF: 4Z-C-121063	- - -	To inquire	Thu 05 Dec 24
Palbociclib Impurity 5 REF: 4Z-P-196009CAS: 2098673-40-4	- - -	To inquire	Thu 05 Dec 24
Leuprorelin (Leuprolide) Impurity 4 ((3-9)-Leuprorelin (Leuprolide)) Ditrifluoroacetate REF: 4Z-PL-4119CAS: 121962-61-6	- - -	To inquire	Thu 05 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Carfilzomib Impurity 15

Ref: 4Z-C-121018

Nintedanib-d8 (Intedanib-d8)

Ref: 4Z-N-066045

Lenvatinib Impurity 15

Ref: 4Z-L-124019

Olaparib Impurity 15

Ref: 4Z-O-032017

Olaparib Impurity 25

Ref: 4Z-O-032027

Abiraterone-d4

Ref: 4Z-A-821

Palbociclib Impurity 56

Ref: 4Z-P-196063

Palbociclib

Ref: 4Z-P-196001

Nintedanib Impurity 13 (Intedanib Impurity 13)

Ref: 4Z-N-066027

Nintedanib Impurity 5 (Intedanib Impurity 5)

Ref: 4Z-N-066014

Enzalutamide Impurity 11

Ref: 4Z-E-068024

Carfilzomib Impurity 2

Ref: 4Z-C-121005

5-9-Leuprorelin Ditrifluoroacetate (5-9-Leuprolide Ditrifluoroacetate)

Ref: 4Z-PL-4115

Nintedanib N4-Oxide Trifluoroacetate (Intedanib N4-Oxide Trifluoroacetate)

Ref: 4Z-N-066025

Palbociclib Impurity 4

Ref: 4Z-P-196008

Leuprorelin (Leuprolide) Impurity 9

Ref: 4Z-PL-4128

Abiraterone Impurity 15

Ref: 4Z-A-8252

Carfilzomib Impurity 60

Ref: 4Z-C-121063

Palbociclib Impurity 5

Ref: 4Z-P-196009

Leuprorelin (Leuprolide) Impurity 4 ((3-9)-Leuprorelin (Leuprolide)) Ditrifluoroacetate

Ref: 4Z-PL-4119